Jingjing Li
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- Molecular Biology top 5%
- RNA modifications and cancer 15
- Epigenetics and DNA Methylation 14
- Cancer-related gene regulation 9
- RNA Research and Splicing 8
- Immunology top 5%
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 8
- Oncology top 5%
- Epidemiology top 10%
- Adipokines, Inflammation, and Metabolic Diseases 9
- Journals
- Scientific Reports (8 papers)Frontiers in Cell and Developmental Biology (5 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Jingjing Li
157 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 163
- Cancer Research 508
- Molecular Biology 1.9k
- Immunology 504
- Oncology 486
- Epidemiology 417
Countries citing papers authored by Jingjing Li
This map shows the geographic impact of Jingjing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Li more than expected).
Fields of papers citing papers by Jingjing Li
This network shows the impact of papers produced by Jingjing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Li. The network helps show where Jingjing Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingjing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 15 | |
| 13 | 2020 | 37 | |
| 14 | 2020 | 34 | |
| 15 | 2019 | 3 | |
| 16 | 2018 | 58 | |
| 17 | 2017 | 56 | |
| 18 | 2017 | 58 | |
| 19 | 2017 | 43 | |
| 20 | 2014 | 16 |
About Jingjing Li
Jingjing Li is a scholar working on Immunology, Reproductive Medicine, Cancer Research, Molecular Biology and Business and International Management, having authored 171 papers that have together received 3.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Epigenetics and DNA Methylation (14 papers), Cancer-related gene regulation (9 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers), RNA Research and Splicing (8 papers), Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (8 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Cancer Research (508 citations), Molecular Biology (1.9k citations), Immunology (504 citations), Oncology (486 citations) and Epidemiology (417 citations). Jingjing Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Lijun Di, Peipei Li, Yuchen Zhang, Tony W. Tong, Mao Tian, Bo Liu, Gu He, Bowen Ke, M Snyder and Dapeng Hao. Their work appears in journals such as Scientific Reports, Frontiers in Cell and Developmental Biology, PLoS ONE, Foods and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.